Trials / Completed
CompletedNCT03647189
Randomized, Controlled Trial With Hybrid Fractional Laser
Randomized, Controlled Trial With Hybrid Fractional Laser for Vulvovaginal Atrophy in Breast Cancer Survivors and Menopausal Females
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Sciton · Industry
- Sex
- Female
- Age
- 40 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This randomized, controlled trial will evaluate hybrid fractional laser treatment for vulvovaginal atrophy in breast cancer survivors and menopausal females
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Hybrid Fractional Laser | Hybrid Fractional Laser |
Timeline
- Start date
- 2018-08-10
- Primary completion
- 2021-06-15
- Completion
- 2021-06-15
- First posted
- 2018-08-27
- Last updated
- 2021-06-18
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03647189. Inclusion in this directory is not an endorsement.